Items where authors include "Eyre, D"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 7.

Article

Tomic, A, Skelly, DT, Ogbe, A et al. (105 more authors) (2022) Divergent trajectories of antiviral memory after SARS-CoV-2 infection. Nature Communications, 13 (1). 1251. ISSN 2041-1723

Aggarwal, D, Page, AJ, Schaefer, U et al. (602 more authors) (2022) Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission. Nature Communications, 13 (1). 1012.

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Aggarwal, D, Warne, B, Jahun, AS et al. (725 more authors) (2022) Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission. Nature Communications, 13 (1). 751. ISSN 2041-1723

Angyal, A, Longet, S, Moore, SC et al. (176 more authors) (2022) T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. The Lancet Microbe, 3 (1). e21-e31. ISSN 2666-5247

Payne, RP, Longet, S, Austin, JA et al. (132 more authors) (2021) Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell, 184 (23). 5699-5714.e11. ISSN 0092-8674

Ogbe, A, Kronsteiner, B, Skelly, DT et al. (77 more authors) (2021) T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nature Communications, 12 (1). 2055.

This list was generated on Sat Apr 27 15:11:18 2024 BST.